Anika Therapeutics 2024 Sidoti Virtual Investor Conference

Anika Therapeutics presented its refocused business strategy at the August 2024 Sidoti Virtual Investor Conference, highlighting #1 U.S. market share in OA Pain management and recent product launches including the Integrity Implant System. The company reported $167M TTM revenue, achieved $10M annualized cost savings, and projects 2024 revenue of $168–$173M with accelerated path to profitability.